1- (3,3-Dimethylbutyl) -3- (2-fluoro-4-methyl-5- (7-methyl-2- (methylamino) pyrido (2,3-d) pyrimidin-6-yl) phenyl) urea as a Raf kinase inhibitor for cancer treatment
Eli Lilly and Company;Deciphera Pharmaceuticals, LLC
发明人:
ALLGEIER, Matthew Carl,FLYNN, Daniel L.,KAUFMAN, Michael D.,PATEL, Phenil J.,WOLFANGEL, Craig D.
申请号：
ES13712005
公开号：
ES2584387T3
申请日:
2013.03.05
申请国别(地区):
ES
年份:
2016
代理人:
摘要：
A compound that is 1- (3,3-dimethylbutyl) -3- (2-fluoro-4-methyl-5- (7-methyl-2- (methylamino) pyrido [2,3-d] pyrimidin-6- yl ) phenyl) urea, or a pharmaceutically acceptable salt thereof.Un compuesto que es 1-(3,3-dimetilbutil)-3-(2-fluoro-4-metil-5-(7-metil-2-(metilamino)pirido[2,3-d]pirimidin-6- il)fenil)urea, o una sal farmacéuticamente aceptable del mismo.
